Alcon Pulls CyPass Glaucoma Micro-Stent Off the Global Market Alcon Pulls CyPass Glaucoma Micro-Stent Off the Global Market

The company cites 5-year safety data that show statistically significant endothelial cell loss in patients who received the CyPass stent at the time of glaucoma surgery.News Alerts
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Ophthalmology News Alert Source Type: news